Accelerate Diagnostics, INC DEF 14A proxy statements
Proxy statements, covering the matters put to shareholders at the annual meeting — board elections, auditor ratification and executive pay.
Accelerate Diagnostics is holding its 2024 Annual Meeting of Shareholders on May 7, 2024, to vote on the election of directors, ratification of Ernst & Young LLP as the independent auditor, and an amendment to the 2022 Omnibus Equity Incentive Plan.